BioCentury | Mar 19, 2020
Product Development
Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more
...the pretreatment pool to be dosed if they become infected by SARS-CoV-2. According to ClinicalTrials.gov, Pulmotect Inc....